Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus

被引:0
作者
Li, TC
Zhang, J
Shinzawa, H
Ishibashi, M
Sata, M
Mast, EE
Kim, K
Miyamura, T
Takeda, N
机构
[1] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan
[2] Epidem Prevent Stn Heilongjiang, Harbin, Peoples R China
[3] Yamagata Univ, Sch Med, Dept Internal Med, Yamagata 99023, Japan
[4] Kurume Univ, Sch Med, Dept Internal Med 2, Kurume, Fukuoka 830, Japan
[5] Ctr Dis Control & Prevent, Hepatitis Branch, Atlanta, GA USA
[6] Natl Inst Hlth, Dept Virol, Seoul, South Korea
关键词
ELISA; recombinant HEV; VLP; anti-HEV IgM; anti-HEV IgG;
D O I
10.1002/1096-9071(200011)62:3<327::AID-JMV4>3.0.CO;2-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis E, an enterically transmitted non-A, non-B hepatitis, is a serious viral infection that occasionally causes large epidemics in developing countries. In developed countries, the disease only appears sporadically due to the transmission routes, and it is considered to be less important. The hepatitis E virus (HEV) cannot grow in cultured cells and no reliable assay system has ever been developed. In addition, the present diagnostic are not perfect, and actual rates of HEV infection may be underestimated. Highly purified empty virus-like particles (VLPs) of HEV have been produced by the use of a recombinant baculovirus vector in insect cells. Using these VLPs as an antigen, an enzyme-linked immunosorbent assay (ELISA) for antibodies to HEV was developed. A panel of 164 sera that were randomized and coded, and sera collected periodically from three patients with hepatitis E were used for the evaluation. The sensitivity of the assay was shown to be equal to or better than that obtained in previous research that used the same serum panel. The ELISA demonstrated that the serum IgM level of the patients was highest at the onset of the clinical illness and then rapidly decreased. In contrast, a high level of circulating IgG antibody titers lasted for more than 4 years. In Japan, a non-endemic country, the prevalence of the IgG class antibody to HEV in healthy individuals was found to range from 1.9% to 14.1%, depending on the geographical area. Only one out of 900 (0.1%) serum samples was IgM-positive. The IgM class antibody to HEV was detected in 10.8% of non-A, non-B, and non-C acute hepatitis patients in northeast China, whereas none of the patients in Korea had the IgM antibody. The ELISA utilizing the VLPs is sensitive and specific in its detection of the IgM and IgG antibodies to HEV. The ELISA is therefore useful for diagnosing HEV infection and for seroepidemiological study of hepatitis E. J. Med. Virol. 62:327-333, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 33 条
[1]  
ARANKALLE VA, 1988, LANCET, V1, P550
[2]   AGE-SPECIFIC PREVALENCE OF ANTIBODIES TO HEPATITIS-A AND HEPATITIS-E VIRUSES IN PUNE, INDIA, 1982 AND 1992 [J].
ARANKALLE, VA ;
TSAREV, SA ;
CHADHA, MS ;
ALLING, DW ;
EMERSON, SU ;
BANERJEE, K ;
PURCELL, RH .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) :447-450
[3]   EVIDENCE FOR A VIRUS IN NON-A, NON-B HEPATITIS TRANSMITTED VIA THE FECAL-ORAL ROUTE [J].
BALAYAN, MS ;
ANDJAPARIDZE, AG ;
SAVINSKAYA, SS ;
KETILADZE, ES ;
BRAGINSKY, DM ;
SAVINOV, AP ;
POLESCHUK, VF .
INTERVIROLOGY, 1983, 20 (01) :23-31
[4]   ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS - SERIAL PASSAGE OF DISEASE IN CYNOMOLGUS MACAQUES AND TAMARINS AND RECOVERY OF DISEASE-ASSOCIATED 27-NM TO 34-NM VIRUS-LIKE PARTICLES [J].
BRADLEY, DW ;
KRAWCZYNSKI, K ;
COOK, EH ;
MCCAUSTLAND, KA ;
HUMPHREY, CD ;
SPELBRING, JE ;
MYINT, H ;
MAYNARD, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) :6277-6281
[5]   EPIDEMIC HEPATITIS-E IN PAKISTAN - PATTERNS OF SEROLOGIC RESPONSE AND EVIDENCE THAT ANTIBODY TO HEPATITIS-E VIRUS PROTECTS AGAINST DISEASE [J].
BRYAN, JP ;
TSAREV, SA ;
IQBAL, M ;
TICEHURST, J ;
EMERSON, S ;
AHMED, A ;
DUNCAN, J ;
RAFIQUI, AR ;
MALIK, IA ;
PURCELL, RH ;
LEGTERS, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :517-521
[6]   SOLID-PHASE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR HEPATITIS-E VIRUS IGG AND IGM ANTIBODIES UTILIZING RECOMBINANT ANTIGENS AND SYNTHETIC PEPTIDES [J].
DAWSON, GJ ;
CHAU, KH ;
CABAL, CM ;
YARBOUGH, PO ;
REYES, GR ;
MUSHAHWAR, IK .
JOURNAL OF VIROLOGICAL METHODS, 1992, 38 (01) :175-186
[7]   A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques [J].
Erker, JC ;
Desai, SM ;
Schlauder, GG ;
Dawson, GJ ;
Mushahwar, IK .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :681-690
[8]   SEROLOGIC IDENTIFICATION OF HEPATITIS-E VIRUS-INFECTIONS IN EPIDEMIC AND ENDEMIC SETTINGS [J].
FAVOROV, MO ;
FIELDS, HA ;
PURDY, MA ;
YASHINA, TL ;
ALEKSANDROV, AG ;
ALTER, MJ ;
YARASHEVA, DM ;
BRADLEY, DW ;
MARGOLIS, HS .
JOURNAL OF MEDICAL VIROLOGY, 1992, 36 (04) :246-250
[9]   EXPRESSION AND DIAGNOSTIC UTILITY OF HEPATITIS-E VIRUS PUTATIVE STRUCTURAL PROTEINS EXPRESSED IN INSECT CELLS [J].
HE, JK ;
TAM, AW ;
YARBOUGH, PO ;
REYES, GR ;
CARL, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (08) :2167-2173
[10]  
HSIEH SY, 1999, INTERVIROLOGY, V42, P252